Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Sars-Cov-2 Omicron (B.1.1.529) Variant: No Time to Wait! Publisher Pubmed



Rahmani S1, 2 ; Rezaei N2, 3, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  3. 3. Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: Acta Biomedica Published:2022


Abstract

On November 26th, a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), B.1.1.529, was designated by the World Health Organization (WHO) as a variant of concern (VOC) and named Omicron. The news raised an international alarm about a new wave of coronavirus disease 2019 (Covid-19) outbreak, since Omicron has a large group of mutations, which may affect the way it spread, cause disease, and escape from the immunity. Therefore, it is essential to take a closer look at how it has emerged, how it may sustain the pandemic, and how we can act correspondingly, both nationally and internationally, to help controlling the spread of the disease. (www.actabiomedica.it). © Mattioli 1885.
Related Docs
1. Sars-Cov-2 Omicron (B.1.1.529) Variant: A Challenge With Covid-19, Diagnostics (2023)
2. Omicron (B.1.1.529) Variant: Development, Dissemination, and Dominance, Journal of Medical Virology (2022)
3. Molecular Variants of Sars-Cov-2: Antigenic Properties and Current Vaccine Efficacy, Medical Microbiology and Immunology (2022)
4. Physical Activity and Covid-19 Severity and Mortality, Physical Activity and Pandemics: Lessons Learned from COVID-19 (2023)
5. Association Between Physical Activity and Risk of Covid-19 Infection or Clinical Outcomes of the Patients With Covid-19: A Systematic Review and Meta-Analysis, Journal of Preventive Medicine and Hygiene (2023)
6. Omicron Variant of Covid-19: A Focused Review of Biologic, Clinical, and Epidemiological Changes, Immunopathologia Persa (2023)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (1)
Farzin Halabchi (1)